Newmedica ophthalmologist Richard Stead provided HSOC delegates with an overview of contemporary treatment options ...
Philanthropy, advocacy and artistry were jointly honored at the Glaucoma Foundation's Annual Gala on April 16, at which 300 supporters and friends gathered to celebrate the Foundation's 42nd ...
Claims from 192,793 newly diagnosed dry eye disease patients showed prescription initiation in 12.4%, indicating substantial ...
A survey found high satisfaction rates among eye care practitioners who prescribed Vyzulta to treat open-angle glaucoma or ...
Global Glaucoma Surgery Devices Market OverviewThe global glaucoma surgery devices market is projected to expand at a steady growth rate of approximately 5% over the next five years, reflecting ...
A smart contact lens described in a research paper on Wednesday combines therapeutic and diagnostic capabilities for glaucoma ...
India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...
OSRX partners with pro rodeo star Sam Petersen to expand Ride with OSRX, highlighting precision, performance, and growth in ...
A trio of ASCRS presentations collectively offer insight to surgeons, suggesting that glaucoma drops harm meibomian glands, ...
On March 9, 2026, SpyGlass Pharma announced positive 12-month results from its phase 1/2 trial of the Bimatoprost Drug ...
Free glaucoma screening camp at SHO building in Brodipet, Guntur on Sunday; ophthalmologists to offer consultations and awareness session on eye health.
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results